0

Journal Articles

in Hypertension
 21-40 of 646 Articles
JAMA Internal Medicine | 
Original Investigation |  December 10, 2012
The Risk of Hip Fracture After Initiating Antihypertensive Drugs in the Elderly
Debra A. Butt, MD, MSc, CCFP, FCFP; Muhammad Mamdani, PharmD, MPH; Peter C. Austin, PhD; et al.
Arch Intern Med. 2012;172(22):1739-1744. doi:10.1001/2013.jamainternmed.469.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Research Letters |  December 01, 2012
Ophthalmologic Diagnosis of Exacerbation of Idiopathic Pulmonary Arterial Hypertension
Dimitra Skondra, MD; Grace C. Chang, MD, PhD; Harrison W. Farber, MD; et al.
Arch Ophthalmol. 2012;130(12):1619-1621. doi:10.1001/archophthalmol.2012.1802.
JAMA Neurology | 
Original Contribution |  December 01, 2012
Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
Ihab Hajjar, MD, MS; Lauren Brown, BS, MPH; Wendy J. Mack, PhD; et al.
Arch Neurol. 2012;69(12):1632-1638. doi:10.1001/archneurol.2012.1010.
JAMA | 
Editorial |  November 28, 2012
Heart Failure Therapy:  What Should Clinicians Believe?
James C. Fang, MD
JAMA. 2012;308(20):2144-2146. doi:10.1001/jama.2012.45418.
JAMA | 
Medical News and Perspectives |  November 28, 2012
Consumer Group Asks FDA to Warn Patients About Hypertension Combination Therapy
Mike Mitka, MSJ
JAMA. 2012;308(20):2070-2071. doi:10.1001/jama.2012.25362.
JAMA Internal Medicine | 
Original Investigation |  November 26, 2012
The Effect of Values Affirmation on Race-Discordant Patient-Provider Communication
Edward P. Havranek, MD; Rebecca Hanratty, MD; Channing Tate, MPH; et al.
Arch Intern Med. 2012;172(21):1662-1667. doi:10.1001/2013.jamainternmed.258.
JAMA | 
Viewpoint |  November 07, 2012
Preventing and Controlling Hypertension in the Era of Genomic Innovation and Environmental Transformation
Donna K. Arnett, MSPH, PhD; Steven A. Claas, MS
JAMA. 2012;308(17):1745-1746. doi:10.1001/jama.2012.28747.
JAMA | 
Original Contribution |  October 24, 2012 FREE
Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men
Michel M. Joosten, PhD; Jennifer K. Pai, ScD, MHS; Monica L. Bertoia, MPH, PhD; et al.
JAMA. 2012;308(16):1660-1667. doi:10.1001/jama.2012.13415.
INCLUDES: CME
JAMA | 
From the Centers for Disease Control and Prevention |  October 17, 2012 FREE
QuickStats: FROM THE NATIONAL CENTER FOR HEALTH STATISTICS:  Prevalence of Hypertension Among Mexican-American Adults Aged 20-74 Years, by Country of Birth—United States, 1982-1984 to 2007-2010
JAMA. 2012;308(15):1520. doi:.
JAMA Internal Medicine | 
Original Investigation |  October 08, 2012
The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries:  Results of the Sub-Saharan Africa Survey of Heart Failure
Albertino Damasceno, MD, PhD; Bongani M. Mayosi, DPhil, FCP(SA); Mahmoud Sani, MBBS; et al.
Arch Intern Med. 2012;172(18):1386-1394. doi:10.1001/archinternmed.2012.3310.
JAMA Internal Medicine | 
Invited Commentary |  October 08, 2012
Hypertension as an Emerging Risk Factor for Acute Heart Failure in Africa:  Comment on “The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries”
Kenneth A. Jamerson, MD; Lawrence Agodoa, MD
Arch Intern Med. 2012;172(18):1395-1396. doi:10.1001/archinternmed.2012.4491.
JAMA Internal Medicine | 
Original Investigation |  October 08, 2012
Comparative Effectiveness of 2 β-Blockers in Hypertensive Patients
Emily D. Parker, MPH, PhD; Karen L. Margolis, MD, MPH; Nicole K. Trower, BS; et al.
Arch Intern Med. 2012;172(18):1406-1412. doi:10.1001/archinternmed.2012.4276.
JAMA Internal Medicine | 
Invited Commentary |  October 08, 2012
Observational Comparative Effectiveness Studies of Drug Therapies:  High-Quality Answers or Important Clinical Questions?
Comment on “Comparative Effectiveness of 2 β-Blockers in Hypertensive Patients”
James S. Floyd, MD, MS; Bruce M. Psaty, MD, PhD
Arch Intern Med. 2012;172(18):1412-1414. doi:10.1001/archinternmed.2012.4306.
JAMA | 
Medical News and Perspectives |  October 03, 2012 FREE
Clinicians Remain Reluctant to Allow Negative Findings to Influence Practice
Mike Mitka
JAMA. 2012;308(13):1305-1306. doi:10.1001/2012.jama.12314.
JAMA Internal Medicine | 
Review Article |  September 24, 2012
Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus:  Systematic Review and Meta-analysis
Kerry McBrien, MD, MPH; Doreen M. Rabi, MD, MS; Norm Campbell, MD; et al.
Arch Intern Med. 2012;172(17):1296-1303. doi:10.1001/archinternmed.2012.3147.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Invited Commentary |  September 24, 2012
Use of a Single Target Blood Pressure Level in Type 2 Diabetes Mellitus for All Cardiovascular Risk Reduction:  Comment on “Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus”
Pantelis A. Sarafidis, MD, MSc, PhD; George L. Bakris, MD
Arch Intern Med. 2012;172(17):1304-1305. doi:10.1001/archinternmed.2012.4020.
JAMA Internal Medicine | 
Research Letters |  September 24, 2012
Missed Opportunities for Treatment of Uncontrolled Hypertension at Physician Office Visits in the United States, 2005 Through 2009
Raman Ravi Khanna, MD, MAS; Ronald G. Victor, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Arch Intern Med. 2012;172(17):1344-1345. doi:10.1001/archinternmed.2012.2749.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  September 10, 2012
Antihypertensive Drugs and Lip Cancer in Non-Hispanic Whites
Gary D. Friedman, MD, MS; Maryam M. Asgari, MD, MPH; E. Margaret Warton, MPH; et al.
Arch Intern Med. 2012;172(16):1246-1251. doi:10.1001/archinternmed.2012.2754.
JAMA | 
Editorial |  September 05, 2012
Atherogenic Vascular Stiffness and Hypertension:  Cause or Effect?
Debabrata Mukherjee, MD, MS
JAMA. 2012;308(9):919-920. doi:10.1001/2012.jama.10931.
JAMA | 
Original Contribution |  September 05, 2012 FREE
Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension
Bernhard M. Kaess, MD; Jian Rong, PhD; Martin G. Larson, ScD; et al.
JAMA. 2012;308(9):875-881. doi:10.1001/2012.jama.10503.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
News From the Centers for Disease Control and Prevention  |  May 15, 2013
Hypertension Increasing Among US Adults
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Waste and Harm in the Treatment of Mild Hypertension
Iona Heath, MA, MB, BCh
JAMA Internal Medicine
Research Letters  |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
JAMA Ophthalmology
Research Letters  |  April 01, 2013
Nonarteritic Anterior Ischemic Optic Neuropathy in a 35-Year-Old Postpartum Woman With Recent Preeclampsia
Prashanthi Giridhar, MD; Kenn Freedman, MD, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems